Cargando…

Oral emergency contraception practices of community pharmacies: a mystery caller study in the capital of Germany, Berlin

BACKGROUND: In Germany, oral emergency contraception (EC) with the active ingredients levonorgestrel (LNG) and ulipristal acetate (UPA) is available as over-the-counter (OTC) medicine only from community pharmacies (CPs). Because of the window of effect, which is limited to only a few days, CPs have...

Descripción completa

Detalles Bibliográficos
Autores principales: Lungfiel, Gwenda, Mandlmeier, Franca, Kunow, Christian, Langer, Bernhard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10215052/
https://www.ncbi.nlm.nih.gov/pubmed/37237301
http://dx.doi.org/10.1186/s40545-023-00565-w
_version_ 1785047971326328832
author Lungfiel, Gwenda
Mandlmeier, Franca
Kunow, Christian
Langer, Bernhard
author_facet Lungfiel, Gwenda
Mandlmeier, Franca
Kunow, Christian
Langer, Bernhard
author_sort Lungfiel, Gwenda
collection PubMed
description BACKGROUND: In Germany, oral emergency contraception (EC) with the active ingredients levonorgestrel (LNG) and ulipristal acetate (UPA) is available as over-the-counter (OTC) medicine only from community pharmacies (CPs). Because of the window of effect, which is limited to only a few days, CPs have a great responsibility to provide rapid and unimpeded access, while also ensuring “adequate” counseling. The aim was—for the first time in Europe and thus also in Germany for the methodology used in this study—to investigate immediate availability, pricing, and aspects of counseling. METHODS: Covert mystery calls were conducted in a random sample of CPs stratified by districts in the German capital Berlin. Each of the 263 CPs included was called once at random by one of two trained female student mystery callers. They simulated a product-based scenario for the UPA original ellaOne(®), citing a contraceptive failure one day ago as the reason. RESULTS: Of 257 successfully called CPs, UPA preparations were immediately available in 98.4% (253/257) and LNG preparations in 86.8% (184/212) of CPs. Prices for UPA preparations varied from €15.95 to €42.95 (∆ 169%; median €35.00 [interquartile range (IQR) €5.91]) and for LNG preparations from €10.60 to €32.49 (Δ 207%; median €22.00 [IQR €5.76]). Information about the correct different window of effect of UPA and LNG preparations was provided in 69.8% (127/182) of CPs. UPA preparations were recommended in 63.1% (111/176) and LNG preparations in 17.2% (30/174) of CPs. Information was provided on how to take them as soon as possible in 30.8% (44/143) of CPs and on how to use them after vomiting in 46.0% (64/139). CONCLUSIONS: Berlin CPs support access through high immediate availability, especially to UPA preparations. However, access is hampered by high absolute price ranges of both UPA and LNG preparations, which could ideally be minimized by a comparison app. It is positive that CPs promote the benefits of UPA preparations by recommending them noticeably more often than LNG preparations. However, there are deficiencies in giving advice, so there is a need to raise awareness among pharmacy staff to ensure “adequate” counseling in advance over the phone. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40545-023-00565-w.
format Online
Article
Text
id pubmed-10215052
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-102150522023-05-28 Oral emergency contraception practices of community pharmacies: a mystery caller study in the capital of Germany, Berlin Lungfiel, Gwenda Mandlmeier, Franca Kunow, Christian Langer, Bernhard J Pharm Policy Pract Research BACKGROUND: In Germany, oral emergency contraception (EC) with the active ingredients levonorgestrel (LNG) and ulipristal acetate (UPA) is available as over-the-counter (OTC) medicine only from community pharmacies (CPs). Because of the window of effect, which is limited to only a few days, CPs have a great responsibility to provide rapid and unimpeded access, while also ensuring “adequate” counseling. The aim was—for the first time in Europe and thus also in Germany for the methodology used in this study—to investigate immediate availability, pricing, and aspects of counseling. METHODS: Covert mystery calls were conducted in a random sample of CPs stratified by districts in the German capital Berlin. Each of the 263 CPs included was called once at random by one of two trained female student mystery callers. They simulated a product-based scenario for the UPA original ellaOne(®), citing a contraceptive failure one day ago as the reason. RESULTS: Of 257 successfully called CPs, UPA preparations were immediately available in 98.4% (253/257) and LNG preparations in 86.8% (184/212) of CPs. Prices for UPA preparations varied from €15.95 to €42.95 (∆ 169%; median €35.00 [interquartile range (IQR) €5.91]) and for LNG preparations from €10.60 to €32.49 (Δ 207%; median €22.00 [IQR €5.76]). Information about the correct different window of effect of UPA and LNG preparations was provided in 69.8% (127/182) of CPs. UPA preparations were recommended in 63.1% (111/176) and LNG preparations in 17.2% (30/174) of CPs. Information was provided on how to take them as soon as possible in 30.8% (44/143) of CPs and on how to use them after vomiting in 46.0% (64/139). CONCLUSIONS: Berlin CPs support access through high immediate availability, especially to UPA preparations. However, access is hampered by high absolute price ranges of both UPA and LNG preparations, which could ideally be minimized by a comparison app. It is positive that CPs promote the benefits of UPA preparations by recommending them noticeably more often than LNG preparations. However, there are deficiencies in giving advice, so there is a need to raise awareness among pharmacy staff to ensure “adequate” counseling in advance over the phone. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40545-023-00565-w. BioMed Central 2023-05-26 /pmc/articles/PMC10215052/ /pubmed/37237301 http://dx.doi.org/10.1186/s40545-023-00565-w Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Lungfiel, Gwenda
Mandlmeier, Franca
Kunow, Christian
Langer, Bernhard
Oral emergency contraception practices of community pharmacies: a mystery caller study in the capital of Germany, Berlin
title Oral emergency contraception practices of community pharmacies: a mystery caller study in the capital of Germany, Berlin
title_full Oral emergency contraception practices of community pharmacies: a mystery caller study in the capital of Germany, Berlin
title_fullStr Oral emergency contraception practices of community pharmacies: a mystery caller study in the capital of Germany, Berlin
title_full_unstemmed Oral emergency contraception practices of community pharmacies: a mystery caller study in the capital of Germany, Berlin
title_short Oral emergency contraception practices of community pharmacies: a mystery caller study in the capital of Germany, Berlin
title_sort oral emergency contraception practices of community pharmacies: a mystery caller study in the capital of germany, berlin
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10215052/
https://www.ncbi.nlm.nih.gov/pubmed/37237301
http://dx.doi.org/10.1186/s40545-023-00565-w
work_keys_str_mv AT lungfielgwenda oralemergencycontraceptionpracticesofcommunitypharmaciesamysterycallerstudyinthecapitalofgermanyberlin
AT mandlmeierfranca oralemergencycontraceptionpracticesofcommunitypharmaciesamysterycallerstudyinthecapitalofgermanyberlin
AT kunowchristian oralemergencycontraceptionpracticesofcommunitypharmaciesamysterycallerstudyinthecapitalofgermanyberlin
AT langerbernhard oralemergencycontraceptionpracticesofcommunitypharmaciesamysterycallerstudyinthecapitalofgermanyberlin